Last analyzed: May 28, 2026 (Q1 FY26)

Alnylam Pharmaceuticals, Inc.

ALNY

Biotechnology

$305.06

Market Cap

$41M

P/E Ratio

74.06015

Revenue Rank

Rank 2

Margin Rank

Rank 4

Performance Parameter: Indicating Future Growth(Based on Quarterly Earnings Call)

Explore More Tools

Discover more ways to research and analyze Indian stocks

Stock RankingsAI-ranked stocks from earnings callsStock ScreenerFilter by P/E, ROE, growth & moreIPO DashboardUpcoming, open & listed IPOsCompare StocksSide-by-side stock comparisonCalculatorsSIP, CAGR, EMI & moreEarnings CalendarUpcoming earnings callsAnalyze PortfolioAI health check for your portfolioBlogMarket insights & guides